Compute & Embodied AI Portfolio
I'll dig into the Compute & Embodied AI account. Let me pull the current state and mandate first.
Strong run, Wei. +42% on the account. Let me verify current prices (US pre-market now) and check the concentration math before proposing anything.
Market's closed (Monday pre-market, 07:25 ET); prices below are Friday's close. Here's where the account stands.
Compute & Embodied AI — Scorecard
Equity $1.24M, up +42.1% (+$236.5K). Here's each position against your mandate limits:
What's offside
One hard breach: ARM at 25.4%, way over your 15% single-position cap. Your monster +216% winner has compounded itself into a concentration risk. At its allowed 40% single-stock drawdown, ARM alone could knock ~10% off the whole account. This is a discipline trim, not a thesis change, the edge-AI architecture story is intact.
Two soft items (not violations, but worth flagging):
- Cash at 35.8% is more than double your floor. You're heavily under-deployed for a mandate that's running hot.
- 5 holdings vs the 8–10 the playbook calls for. Thin diversification, which is exactly why ARM's run dominated the book.
Proposed trim (the only mandate-required action)
Sell 360 ARM @ market → leaves 470 shares (~$179K, 14.4%), a hair under the cap for buffer. Frees ~$137K.
That's the clean de-risk. The catch: it pushes cash to ~$583K (47%), even more under-deployed. So the real question is direction:
- Path A — De-risk only: Just trim ARM, sit on cash, wait for a setup. Simplest.
- Path B — Trim + redeploy to mandate: Trim ARM and put part of the cash into 2–3 new embodied-AI/robotics names to get you toward 8–10 holdings and cash back near 15%. I'd need to source candidates that pass your multi-factor screen (valuation + catalyst + technicals aligned).
SYM is your only loser (−16.5%) but it's small and nowhere near the 40% stop, so I'd hold and watch, not act.
Which path, Wei? Confirm and I'll stage the orders, nothing submitted until you sign off. If Path B, I'll bring you a candidate shortlist first.